Ueno, Y., Mori, M., Kamiyama, Y., Saito, R., Kaneko, N., Isshiki, E., . . . Takeuchi, M. (2019). Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD(+) acute myeloid leukemia. Oncotarget.
Chicago Style CitationUeno, Yoko, Masamichi Mori, Yoshiteru Kamiyama, Rika Saito, Naoki Kaneko, Eriko Isshiki, Sadao Kuromitsu, i Masahiro Takeuchi. "Evaluation of Gilteritinib in Combination With Chemotherapy in Preclinical Models of FLT3-ITD(+) Acute Myeloid Leukemia." Oncotarget 2019.
Cita MLAUeno, Yoko, et al. "Evaluation of Gilteritinib in Combination With Chemotherapy in Preclinical Models of FLT3-ITD(+) Acute Myeloid Leukemia." Oncotarget 2019.
Atenció: Aquestes cites poden no estar 100% correctes.